	US 11,986,487 B2
	Mixture of HMOS for treating wheat sensitivity
Louise Kristine Vigsnæs, Copenhagen NV (DK); and Bruce McConnell, La Tour de Peilz (CH)
Assigned to GLYCOM A/S, Hørsholm (DK)
Filed by GLYCOM A/S, Hørsholm (DK)
Filed on Sep. 21, 2022, as Appl. No. 17/934,123.
Application 17/934,123 is a continuation of application No. 16/768,333, granted, now 11,452,736, previously published as PCT/IB2018/059497, filed on Nov. 30, 2018.
Claims priority of application No. PA 2017 00680 (DK), filed on Nov. 30, 2017.
Prior Publication US 2023/0014752 A1, Jan. 19, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/702 (2006.01); A23L 33/00 (2016.01); A23L 33/21 (2016.01); A61P 1/00 (2006.01)

CPC A61K 31/702 (2013.01) [A23L 33/21 (2016.08); A23L 33/40 (2016.08); A61P 1/00 (2018.01)]

19 Claims

1. A method of inducing wheat and/or gluten tolerance in a human patient suffering from non-coeliac wheat and/or gluten sensitivity comprising administering at least one human milk oligosaccharides (HMO) to the patient,

wherein the at least one HMO comprises 2′-FL, DFL, LNT, or LNnT.